New oral formulation for agonists or antagonists of 5-HT4.

solid oral pharmaceutical composition comprising Compound A or its salts; comprising a disintegrant which is present in an amount of at least 15% by weight based on the total weight of the composition, wherein the disintegrant is a member selected from the group consisting of crospovidone, pregelatinized starch, sodium starch glycolate , sodium carboxymethylcellulose, calcium carboxymethylcellulose, sodium alginate, and a mixture thereof.